Q. A patient presents with headache, palpatations and diaphoresis with elevated 24- hour urine metanephrine levels. Which of drug is given preoperatively

Explanation

## Correct Answer: D. Labetalol Labetalol is the gold-standard preoperative agent for pheochromocytoma management in India and globally. The clinical triad of headache, palpitations, and diaphoresis with elevated 24-hour urine metanephrine confirms catecholamine excess. Preoperative preparation requires **dual blockade**: α-adrenergic blockade (to prevent hypertensive crisis and vasospasm during tumor manipulation) followed by β-blockade (to control reflex tachycardia and arrhythmias). Labetalol uniquely provides both α and β-blockade in a single agent (α:β ratio ~1:7), making it ideal for preoperative stabilization. It prevents the "catecholamine storm" during surgical handling of the tumor. Unlike pure β-blockers (which cause unopposed α-mediated vasoconstriction if given alone) or CCBs (which lack α-blockade), labetalol achieves hemodynamic control without the need for sequential drug titration. Standard Indian practice: labetalol 200–400 mg BD–TDS for 7–10 days preoperatively, titrated to achieve BP <160/100 mmHg and HR <90 bpm. This prevents intraoperative hypertensive emergencies and arrhythmias that can precipitate myocardial infarction or stroke. ## Why the other options are wrong **A. CCB** — Calcium channel blockers (nifedipine, amlodipine) provide vasodilation but lack α-adrenergic blockade. They do not prevent catecholamine-induced vasoconstriction or the hypertensive surge during tumor manipulation. CCBs are adjunctive only, never monotherapy for pheochromocytoma. NBE trap: students confuse CCBs' role in hypertension management with pheochromocytoma-specific preoperative needs. **B. Esmolol** — Esmolol is a pure β₁-selective blocker. Giving β-blockade without prior α-blockade causes unopposed α-adrenergic vasoconstriction, leading to paradoxical hypertensive crisis and coronary vasospasm. This is a classic NBE trap: students remember 'beta-blocker for palpitations' but forget the mandatory α-blockade-first rule in pheochromocytoma. Esmolol is contraindicated as monotherapy. **C. Phenoxybenzamine** — Phenoxybenzamine is a non-selective, irreversible α-blocker—essential for initial α-blockade in pheochromocytoma. However, it is given FIRST (7–10 days preoperatively), not as the sole preoperative agent. After α-blockade is established, β-blockade must follow to control reflex tachycardia. Labetalol combines both in one agent, making it the single best preoperative choice. Phenoxybenzamine alone leaves tachycardia uncontrolled. ## High-Yield Facts - **Pheochromocytoma preoperative rule**: α-blockade FIRST, then β-blockade—never reverse the order (unopposed α causes hypertensive crisis). - **Labetalol** is the single agent that provides both α and β-blockade (α:β ~1:7), ideal for preoperative stabilization without sequential drug titration. - **24-hour urine metanephrine** is the gold-standard diagnostic test for pheochromocytoma (>4× upper limit normal confirms diagnosis). - **Preoperative BP target** in pheochromocytoma: <160/100 mmHg and HR <90 bpm to prevent intraoperative hypertensive emergencies and arrhythmias. - **Phenoxybenzamine** (irreversible α-blocker) is used for initial α-blockade (7–10 days), but labetalol is preferred for final preoperative stabilization due to combined action. ## Mnemonics **ALPHA-FIRST Rule** Always block **ALPHA** before **BETA** in pheochromocytoma. Alpha-blockade prevents vasoconstriction; beta-blockade then controls reflex tachycardia. Reverse order = hypertensive crisis. **LAB for pheochromocytoma prep** **L**abetalol = **A**lpha + **B**eta in one agent. Gives both blockades without sequential dosing—perfect for preoperative stabilization. ## NBE Trap NBE pairs pheochromocytoma with "beta-blocker" to trap students into choosing esmolol or other pure β-blockers, forgetting that unopposed α-blockade causes paradoxical hypertensive crisis. The key discriminator is recognizing that labetalol provides BOTH α and β-blockade in a single agent. ## Clinical Pearl In Indian tertiary centers, labetalol 200–400 mg BD is the standard preoperative agent for pheochromocytoma because it prevents the "catecholamine storm" during tumor manipulation—a life-threatening intraoperative complication that can cause MI, stroke, or fatal arrhythmia. Always check 24-hour urine metanephrine before surgery; if >4× normal, ensure 7–10 days of preoperative blockade with labetalol. _Reference: KD Tripathi Ch. 12 (Adrenergic Drugs); Harrison Ch. 387 (Pheochromocytoma)_